Showing session: reset
Dharma Master Jiantai Symposium in Targeted Therapy: Systematic Elucidation of Nononcogene Targets
- Sort by:
- Browse by:
- Permission not
granted for presentation
Chemical biology-based approach to understanding and overcoming resistance of cancers to therapies
Stuart L Schreiber
Harvard University and Broad Institute, Cambridge, MA, United States
- Free
- Coming soon
- Some slides withheld
Inactivating STK11/LKB1 genomic alterations are a major driver of primary resistance to PD-1 axis blockade in non-squamous non-small cell lung cancer
Ferdinandos Skoulidis
The University of Texas MD Anderson Cancer Center, Houston, TX, United States
- Permission not
granted for presentation
Strategies to overcome resistance to targeted therapy of lymphoma based on functional genomic and chemical screens
Louis M Staudt
National Cancer Institute, Bethesda, MD, United States
- Free
- audio + slides
- Some slides withheld
Systematic interrogation of cancer dependencies and synthetic lethal interactions
William C Hahn
Dana-Farber Cancer Inst., Boston, MA, United States